Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Bay Area's ChemoCentryx Gets Up to $100M in New Capital Commitments January 3, 2018 Pharma Giant Merck Sharp & Dohme Could Bring 600 New Jobs to Austin April 13, 2017 Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study May 7, 2017
Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study May 7, 2017
